OVERVIEW

Updates You Should Know About Treating Asthma in Children is organized by Pri-Med. This Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit™.

Effective Date: 12/11/2018.
Expiration Date: 12/11/2021.

Topics: Asthma

Course Description:
Asthma in children is all too often not well controlled. It remains one of the most common chronic illnesses you will manage in your office and one of the most frequent reasons why children are admitted to the hospital. I will discuss recent updates on managing asthma exacerbations with inhaled and oral steroids including the risks and benefits of dexamethasone. In addition, I will review the safety of using long-acting beta agonists in combination with inhaled steroids in children. I will also provide recommendations on when to consider treatment with omalizumab, one of the new asthma biological therapies, which has been approved for children as young as six years of age.

Learning Objectives:
• Effectively utilize long acting beta agonists combined with inhaled steroids in the treatment of asthma in children
• Develop evidence-based strategies for managing asthma exacerbations
• Recognize the risks and benefits of treatment with dexamethasone
• Incorporate omalizumab into the asthma treatment algorithm

Additional details will be posted as soon as they are available.